Dr. Fareed Ali, MD, DABO, FRCS(C)
Ophthalmology, Practicing in Retinal Diseases

Director of Clinical Research
Canadian Centre for Advanced Eye Therapeutics Inc.

Staff Ophthalmologist
Ophthalmic Consultant Centres Inc.
Canadian Centre for Advanced Eye Therapeutics Inc.

 

 

A true Canadian pioneer in treating retinal diseases, Dr. Ali Fareed led the retinal disease division at the OCC to perform the first intraocular injections of the anti-VEGF Avastin and Lucentis in Canada. He was also the innovator behind the development of micropulse laser technology, a safer treatment option for patients with dry AMD and central serous retinopathy. Today, the treatments initiated and created by Dr. Ali are among the most successful therapies used to treat retinal diseases in Canada and the world. As both a passionate doctor and researcher, Dr. Ali continues to research on the application of anti-VEGFs in combination with laser and pharmaceutical treatments to cure retinal diseases.